Proposed McDonald criteria revisions could help diagnose MS patients who would have been missed with earlier versions, an ...
WEST PALM BEACH, Fla. — New research testing the newly proposed McDonald Criteria showed that 32% more patients with a ...
Reports of anaphylaxis associated with the use of glatiramer acetate have prompted the Food and Drug Administration (FDA) to add a Boxed Warning to the prescribing information.
In MS, slowly expanding lesions were linked to more myelin loss in brain regions of damage and in normal-appearing brain ...
A woman who was diagnosed with skin cancer which spread to her lymph nodes has said she is taking part in a clinical trial to ...
A detailed review of a 6-month clinical trial further reinforces strong experimental evidence that a ketogenic diet may offer ...
A NEW 4D brain map of marmosets with multiple sclerosis (MS)-like lesions has revealed potential early warning signs and ...
Tiziana is seeking FDA clearance for a Phase 2 clinical trial testing the safety and efficacy of its foralumab nasal spray in ...
Fourth quarter and full year 2024 BRIUMVI U.S. net revenue of $103.6 million and $310 million, respectivelyTarget guidance of approximately $540 ...
Researchers have created a four-dimensional brain map that reveals how MS-like lesions form, providing new insights into the earliest stages of the disease.
Tolebrutinib had the most protective effect against disability worsening at 6 months in patients with multiple sclerosis who ...
3d
MedPage Today on MSNHigh-Dose Vitamin D Reduces Disease Activity in Early Multiple Sclerosis"It was important to conduct a large randomized controlled trial to evaluate the efficacy of high-dose cholecalciferol as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results